1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

23 Nov 2021
Admin
News Article

Cstone Pharmaceuticals And Jiangsu Hengrui Pharmaceuticals Announce Strategic Partnership And Exclusive Licensing Agreement On Anti-Ctla-4 Monoclonal Antibody Cs1002 In Greater China

Cstone Pharmaceuticals, A Leading Biopharmaceutical Company Focused On The Research, Development, And Commercialization Of Innovative Immuno-Oncology Therapies And Precision Medicines, And Jiangsu Hengrui Pharmaceuticals Today Announced A Strategic Partnership And Exclusive Licensing Agreement On Anti-Ctla-4 Mab Cs1002 In The Greater China Region. This Strategic Partnership Marks Another Milestone In Cstone'S Mission To Introduce Innovative Oncology Therapies In China After The Commercial Launch Of Two First-In-Class Drugs This Year.Under The Terms Of The Agreement, Cstone Will Be Eligible For An Upfront Payment And Potential Milestone Payments Up To $200 Mn In Addition To Double-Digit Royalties. Hengrui Will Obtain The Exclusive Rights For Research, Development, Registration, Manufacturing, And Commercialization Of Anti-Ctla-4 Mab Cs1002 In Greater China. Cstone Will Retain The Rights To Develop And Commercialize Of Cs1002 Outside Of Greater China.Cytotoxic T Lymphocyte Associated Antigen 4 (Ctla-4) Is One Of The Few Clinically Validated Targets For Io Combination Therapies. There Is Only One Anti-Ctla-4 Monoclonal Antibody Approved Globally, And It Is Also Approved In China. According To Evaluatepharma, The Annual Global Revenue Of The Product In 2020 Was Approximately $1.69 Billion. Cs1002 Is An Investigational Anti-Ctla-4 Monoclonal Antibody Being Developed By Cstone Currently In Clinical Development. Results From The Ongoing Ph1A/1B Study Showed That Differentiated Dosing Schedules Of Cs1002 In Combination With Cs1003 (Anti-Pd-1) Were Well-Tolerated And Demonstrated Very Encouraging Efficacy In Anti-Pd-(L)1-Refractory Melanoma, Anti-Pd-(L)1-Refractory Hepatocellular Carcinoma, And Anti-Pd-(L)1-Na

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!